Turn Therapeutics Inc. (TTRX)

Turn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	3.19	0.87	1.18
Cash & Cash Equivalents	3.19	0.87	1.18
Cash Growth	-	-26.11%	-
Other Current Assets	0.2	0.23	0.02
Total Current Assets	3.39	1.1	1.2
Goodwill and Intangibles	-	0.94	0.8
Other Long-Term Assets	-	0.01	0.01
Total Long-Term Assets	-	0.95	0.81
Total Assets	-	2.05	2.01
Current Debt	-	0.04	0.03
Other Current Liabilities	1.06	0.67	0.46
Total Current Liabilities	1.06	0.71	0.49
Long-Term Debt	-	0.08	-
Other Long-Term Liabilities	-	1.44	1.44
Total Long-Term Liabilities	-	1.52	1.44
Total Liabilities	-	2.23	1.93
Total Debt	0.1	0.12	0.03
Debt Growth	-	381.14%	-
Retained Earnings	-	-19.2	-17.43
Shareholders' Equity	1.77	-0.18	0.09
Net Cash (Debt)	3.09	0.75	1.16
Net Cash (Debt) Growth	-	-34.98%	-
Working Capital	2.33	0.39	0.71

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).